Institutional
SECTOR GAMMA AS
CIK 0001475373
$423.5M
Reported AUM
42
Positions
Q1 2026
Period
2026-05-07
Filed
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BMY | BRISTOL-MYERS SQUIBB CO | $64.86 | 2.79% | 49.51% | 15.83% | $50.2M | 11.86% | — | HELD |
| 2 | MRK | MERCK & CO INC | $129.79 | -0.44% | 66.99% | 96.29% | $31.3M | 7.39% | — | HELD |
| 3 | PFE | PFIZER INC | $24.91 | -0.95% | 14.58% | -28.87% | $30.6M | 7.24% | — | HELD |
| 4 | MDT | MEDTRONIC PLC | $85.71 | -2.09% | 1.17% | -23.30% | $24.3M | 5.74% | — | HELD |
| 5 | INCY | INCYTE CORP | $122.99 | -3.23% | 68.14% | 66.17% | $18.9M | 4.46% | — | HELD |
| 6 | AMGN | AMGEN INC | $387.64 | 0.00% | 34.50% | 99.65% | $16.6M | 3.92% | — | HELD |
| 7 | BIIB | BIOGEN INC | $207.93 | -0.62% | 55.75% | -39.36% | $16.5M | 3.90% | — | HELD |
| 8 | ZBH | ZIMMER BIOMET HOLDINGS INC | $94.96 | -2.25% | 6.96% | -31.43% | $14.1M | 3.33% | — | HELD |
| 9 | BMRN | BIOMARIN PHARMACEUTICAL INC | $60.58 | -1.29% | 4.55% | -27.81% | $13.6M | 3.20% | — | HELD |
| 10 | BDX | BECTON DICKINSON & CO | $165.45 | -1.75% | 24.43% | -4.83% | $13.0M | 3.07% | — | HELD |
| 11 | ELV | ELEVANCE HEALTH INC FORMERLY | $376.40 | 0.11% | 39.92% | 7.81% | $12.9M | 3.04% | — | HELD |
| 12 | IONS | IONIS PHARMACEUTICALS INC | $53.28 | -1.41% | 25.59% | 35.92% | $12.7M | 3.00% | — | HELD |
| 13 | CAH | CARDINAL HEALTH INC | $227.07 | -0.89% | 46.46% | 380.36% | $11.6M | 2.74% | — | HELD |
| 14 | UNH | UNITEDHEALTH GROUP INC | $421.47 | 0.21% | 80.84% | 9.82% | $9.9M | 2.33% | — | HELD |
| 15 | CVS | CVS HEALTH CORP | $105.22 | -0.66% | 74.93% | 44.72% | $9.7M | 2.30% | — | HELD |
| 16 | BRKR | BRUKER CORP | $64.34 | 4.21% | 63.32% | -28.90% | $9.2M | 2.17% | — | HELD |
| 17 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $69.94 | -2.73% | 3.13% | 4.04% | $9.0M | 2.12% | — | HELD |
| 18 | ABT | ABBOTT LABS | $105.61 | -2.21% | -15.48% | -8.29% | $9.0M | 2.12% | — | HELD |
| 19 | GILD | GILEAD SCIENCES INC | $131.28 | -1.09% | 20.33% | 118.88% | $7.4M | 1.75% | — | HELD |
| 20 | LNTH | LANTHEUS HLDGS INC | $101.00 | 1.00% | 41.70% | 279.22% | $7.1M | 1.67% | — | HELD |
| 21 | IQV | IQVIA HLDGS INC | $237.79 | -3.95% | 32.31% | -7.06% | $6.9M | 1.62% | — | HELD |
| 22 | SNDX | SYNDAX PHARMACEUTICALS INC | $19.48 | 1.35% | 92.38% | 9.78% | $6.7M | 1.58% | — | HELD |
| 23 | BIO | BIO RAD LABS INC | $326.72 | -0.16% | 13.26% | -59.95% | $6.6M | 1.56% | — | HELD |
| 24 | QGEN | QIAGEN NV | $41.45 | -0.86% | -15.52% | -24.10% | $6.5M | 1.54% | — | HELD |
| 25 | AVTR | AVANTOR INC | $13.86 | -3.62% | 22.58% | -64.69% | $5.5M | 1.29% | — | HELD |
| 26 | CNC | CENTENE CORP DEL | $60.84 | -1.59% | 136.03% | -2.90% | $5.3M | 1.26% | — | HELD |
| 27 | TNDM | TANDEM DIABETES CARE INC | $19.01 | 2.26% | 18.31% | -83.76% | $5.1M | 1.21% | — | HELD |
| 28 | PTCT | PTC THERAPEUTICS INC | $75.52 | 1.38% | 42.46% | 70.14% | $5.1M | 1.21% | — | HELD |
| 29 | LH | LABCORP HOLDINGS INC | $315.53 | 2.73% | 17.58% | 22.84% | $5.1M | 1.20% | — | HELD |
| 30 | ASNDUSD | ASCENDIS PHARMA A/S | — | — | — | — | $4.9M | 1.15% | — | HELD |
| 31 | EW | EDWARDS LIFESCIENCES CORP | $86.92 | 1.35% | — | — | $4.8M | 1.14% | — | HELD |
| 32 | DXCM | DEXCOM INC | $74.54 | -0.80% | — | — | $3.5M | 0.83% | — | HELD |
| 33 | CRNX | CRINETICS PHARMACEUTICALS IN | $83.63 | -0.30% | — | — | $3.4M | 0.81% | — | HELD |
| 34 | KURA | KURA ONCOLOGY INC | $9.31 | 4.26% | — | — | $3.3M | 0.79% | — | HELD |
| 35 | HUM | HUMANA INC | $366.66 | 0.34% | — | — | $3.3M | 0.79% | — | HELD |
| 36 | BBIO | BRIDGEBIO PHARMA INC | $82.14 | -1.68% | — | — | $3.3M | 0.78% | — | HELD |
| 37 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $4.69 | 2.85% | — | — | $3.2M | 0.75% | — | HELD |
| 38 | DNLI | DENALI THERAPEUTICS INC | $24.35 | 2.10% | — | — | $3.1M | 0.74% | — | HELD |
| 39 | ARDX | ARDELYX INC | $5.04 | 0.80% | — | — | $3.1M | 0.73% | — | HELD |
| 40 | COGT | COGENT BIOSCIENCES INC | $41.36 | 4.52% | — | — | $3.1M | 0.73% | — | HELD |
| 41 | OGN | ORGANON & CO | $13.55 | 0.07% | — | — | $2.3M | 0.53% | — | HELD |
| 42 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $87.32 | 1.28% | — | — | $1.9M | 0.44% | — | HELD |
Source: SEC EDGAR · accession 0000945621-26-000644. 13F discloses long positions only — shorts, foreign equities, and options are excluded.